EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrative Approach for Designing Novel Triazole Derivatives as α-Glucosidase Inhibitors: QSAR, Molecular Docking, ADMET, and Molecular Dynamics Investigations

Oussama Abchir iD, Meriem Khedraoui, Hassan Nour, Imane Yamari, Abdelkbir Errougui iD, Abdelouahid Samadi iD, Samir Chtita iD

Pharmaceuticals · 19.02.2024 · 17 (2) · 261

DOI: 10.3390/ph17020261 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 19.02.2024. Verfasst von Oussama Abchir und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Analytical and Molecular Chemistry, Faculty of Sciences Ben M'Sik, Hassan II University of Casablanca, Casablanca 7955, Morocco. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: United Arab Emirates University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In response to the increasing prevalence of diabetes mellitus and the limitations associated with the current treatments, there is a growing need to develop novel medications for this disease. This study is focused on creating new compounds that exhibit a strong inhibition of alpha-glucosidase, which is a pivotal enzyme in diabetes control. A set of 33 triazole derivatives underwent an extensive QSAR analysis, aiming to identify the key factors influencing their inhibitory activity against α-glucosidase. Using the multiple linear regression (MLR) model, seven promising compounds were designed as potential drugs. Molecular docking and dynamics simulations were employed to shed light on the mode of interaction between the ligands and the target, and the stability of the obtained complexes. Furthermore, the pharmacokinetic properties of the designed compounds were assessed to predict their behavior in the human body. The binding free energy was also calculated using MMGBSA method and revealed favorable thermodynamic properties. The results highlighted three novel compounds with high biological activity, strong binding affinity to the target enzyme, and suitability for oral administration. These results offer interesting prospects for the development of effective and well-tolerated medications against diabetes mellitus.

Schlagwörter

Stichwörter der Autor:innen

ADMETQSARdiabetes mellitusdynamics simulationmolecular dockingtriazoles

Autor:innen und Institutionen

  • Laboratory of Analytical and Molecular Chemistry, Faculty of Sciences Ben M'Sik, Hassan II University of Casablanca, Casablanca 7955, Morocco.
  • Department of Chemistry, College of Science, United Arab Emirates University (UAEU), Al Ain P.O. Box 15551, United Arab Emirates.

ORCID-Profile: Oussama Abchir, Abdelkbir Errougui, Abdelouahid Samadi, Samir Chtita

Förderung

  • United Arab Emirates University

Zitieren

APA

Abchir, O., Khedraoui, M., Nour, H., Yamari, I., Errougui, A., Samadi, A., & Chtita, S. (2024). Integrative Approach for Designing Novel Triazole Derivatives as α-Glucosidase Inhibitors: QSAR, Molecular Docking, ADMET, and Molecular Dynamics Investigations. Pharmaceuticals, 17(2), 261. https://doi.org/10.3390/ph17020261

Vancouver

Abchir O, Khedraoui M, Nour H, Yamari I, Errougui A, Samadi A, et al. Integrative Approach for Designing Novel Triazole Derivatives as α-Glucosidase Inhibitors: QSAR, Molecular Docking, ADMET, and Molecular Dynamics Investigations. Pharmaceuticals. 2024;17(2):261. doi:10.3390/ph17020261

BibTeX
@article{Abchir2024,
  author = {Abchir, Oussama and Khedraoui, Meriem and Nour, Hassan and Yamari, Imane and Errougui, Abdelkbir and Samadi, Abdelouahid and Chtita, Samir},
  title = {Integrative Approach for Designing Novel Triazole Derivatives as α-Glucosidase Inhibitors: QSAR, Molecular Docking, ADMET, and Molecular Dynamics Investigations},
  journal = {Pharmaceuticals},
  year = {2024},
  volume = {17},
  number = {2},
  pages = {261},
  doi = {10.3390/ph17020261}
}
Kostenlos starten →